Stay updated with breaking news from Akoya biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $2.08, for a total value of $15,600.00. Following the completion of the sale, the chief executive officer now owns 224,733 shares of […] ....
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $2.08, for a total value of $15,600.00. Following the transaction, the chief executive officer now directly owns 224,733 shares […] ....
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, an increase of 11.5% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 276,300 shares, the days-to-cover […] ....
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Theravance Biopharma (TBPH) businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Capital One Financial lowered their Q2 2024 EPS estimates for shares of Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will earn ($0.28) per share for the quarter, down from their prior estimate […] ....